English

{"items":["5c0e14177819a602c7e837e6","5c0e14177819a602c7e837e7","5c0e14177819a602c7e837e9","5c0e14177819a602c7e837ea","5c330b9a4fcbdd001c4013f2","5c331237ced0d7001cf19d2e","5c33128b5234fc001b85b2ff","5f38c7484c6aa400170cf844","5c2e202c15d423001cb28723","5c2e1f3e59d140001cf85901","5c2e1af0bd92d6001cdd7507","5c2e1a3a75e256001bc4719a","5c2e1108827b50001c0402fc","5c2e0ecd6c9e34001c7e8770","5c2e0d6e97533b001c04a820","5c2e00789b4809001c09a591","5c2de2c35a0cd7001cd10962","5c2de24c9b4809001c096de8","5c2ddfe243fecf001cb7ce35","5c2dde780dd718001c296c36"],"styles":{"galleryType":"Columns","groupSize":1,"showArrows":true,"cubeImages":true,"cubeType":"min","cubeRatio":2.2857142857142856,"isVertical":true,"gallerySize":30,"collageAmount":0,"collageDensity":0,"groupTypes":"1","oneRow":false,"imageMargin":32,"galleryMargin":0,"scatter":0,"chooseBestGroup":true,"smartCrop":false,"hasThumbnails":false,"enableScroll":true,"isGrid":true,"isSlider":false,"isColumns":false,"isSlideshow":false,"cropOnlyFill":false,"fixedColumns":0,"enableInfiniteScroll":true,"isRTL":false,"minItemSize":50,"rotatingGroupTypes":"","rotatingCropRatios":"","columnWidths":"","gallerySliderImageRatio":1.7777777777777777,"numberOfImagesPerRow":3,"numberOfImagesPerCol":1,"groupsPerStrip":0,"borderRadius":0,"boxShadow":0,"gridStyle":0,"mobilePanorama":false,"placeGroupsLtr":false,"viewMode":"preview","thumbnailSpacings":4,"galleryThumbnailsAlignment":"bottom","isMasonry":false,"isAutoSlideshow":false,"slideshowLoop":false,"autoSlideshowInterval":4,"bottomInfoHeight":0,"titlePlacement":"SHOW_BELOW","galleryTextAlign":"center","scrollSnap":false,"itemClick":"nothing","fullscreen":true,"videoPlay":"hover","scrollAnimation":"NO_EFFECT","slideAnimation":"SCROLL","scrollDirection":0,"scrollDuration":400,"overlayAnimation":"FADE_IN","arrowsPosition":0,"arrowsSize":23,"watermarkOpacity":40,"watermarkSize":40,"useWatermark":true,"watermarkDock":{"top":"auto","left":"auto","right":0,"bottom":0,"transform":"translate3d(0,0,0)"},"loadMoreAmount":"all","defaultShowInfoExpand":1,"allowLinkExpand":true,"expandInfoPosition":0,"allowFullscreenExpand":true,"fullscreenLoop":false,"galleryAlignExpand":"left","addToCartBorderWidth":1,"addToCartButtonText":"","slideshowInfoSize":200,"playButtonForAutoSlideShow":false,"allowSlideshowCounter":false,"hoveringBehaviour":"NEVER_SHOW","thumbnailSize":120,"magicLayoutSeed":1,"imageHoverAnimation":"NO_EFFECT","imagePlacementAnimation":"NO_EFFECT","calculateTextBoxWidthMode":"PERCENT","textBoxHeight":248,"textBoxWidth":200,"textBoxWidthPercent":50,"textImageSpace":10,"textBoxBorderRadius":0,"textBoxBorderWidth":0,"loadMoreButtonText":"","loadMoreButtonBorderWidth":1,"loadMoreButtonBorderRadius":0,"imageInfoType":"ATTACHED_BACKGROUND","itemBorderWidth":1,"itemBorderRadius":0,"itemEnableShadow":false,"itemShadowBlur":20,"itemShadowDirection":135,"itemShadowSize":10,"imageLoadingMode":"BLUR","expandAnimation":"NO_EFFECT","imageQuality":90,"usmToggle":false,"usm_a":0,"usm_r":0,"usm_t":0,"videoSound":false,"videoSpeed":"1","videoLoop":true,"gallerySizeType":"px","gallerySizePx":940,"allowTitle":true,"allowContextMenu":true,"textsHorizontalPadding":-30,"itemBorderColor":{"value":"rgba(204, 204, 204, 0.75)"},"showVideoPlayButton":true,"galleryLayout":2,"calculateTextBoxHeightMode":"MANUAL","textsVerticalPadding":-15,"targetItemSize":940,"selectedLayout":"2|bottom|1|min|true|0|true","layoutsVersion":2,"selectedLayoutV2":2,"isSlideshowFont":true,"externalInfoHeight":248,"externalInfoWidth":0},"container":{"width":940,"galleryWidth":972,"galleryHeight":0,"scrollBase":0,"height":null}}

2/3

Not compatible with Internet Explorer

Not compatible with Internet Explorer

Not compatible with Internet Explorer

Kadimastem and The AFDR Selected to Receive a bi-National Grant

Kadimastem has Upgraded its Manufacturing Site for Treatment of ALS Patients in the Clinical Trial

Kadimastem was honored with a prize for excellence for the presentation of the company's technology

Initiation of coverage report on Kadimastem by global research firm Frost & Sullivan:

Scientific Article by Kadimastem: Cell-Based Treatment for ALS was Published

Successful Public Offering for Kadimastem

Kadimastem Announces the Enrollment of the First Patient for Its Clinical Trial in ALS Patients

Kadimastem Collaborates with French SME Defymed to Validate a Combined Solution for Type 1 Diabetes

Successful Rights Offering for Kadimastem; Raised NIS 5.1M

Kadimastem to Raise up to NIS 10M in Rights Offering

Kadimastem Received Response from FDA:

Kadimastem Approached the FDA Regarding Its ALS Treatment

Kadimastem to collaborate with Merck Serono to advance efforts in neurodegenerative diseases

Chief Scientist Increases Budget to Advance Kadimastem's Cell Therapy for ALS

Success in Kadimastem’s First Pre-Clinical Trial for Treatment of Amyotrophic Lateral Sclerosis (ALS

Kadimastem Receives Approval for U.S. Patent

Leading pharma entrepreneur Avi Meizler believes in Kadimastem!

Kadimastem announces its intention to reduce the exercise price for warrants (Series 1)

Kadimastem Augments the Company's ALS Activities

Kadimastem has received approval from the OCS to promote cell therapy